---
schema_version: "secwatch.filing_event.v1"
accession: "0000721371-23-000083"
form_type: "8-K"
ticker: "CAH"
cik: "0000721371"
company_name: "CARDINAL HEALTH INC"
filed_at: "2023-11-03T23:59:59+00:00"
generated_at: "2026-06-08T22:52:03.756700+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Cardinal Health Q1 revenue +10% to $54.8B; raises FY24 non-GAAP EPS guidance to $6.75-$7.00

## Summary
- GAAP operating loss $14M due to $581M Medical goodwill impairment; GAAP diluted EPS $0.02.
- Non-GAAP operating earnings $571M (+35%); non-GAAP diluted EPS $1.73 (+44%) vs. $1.20.
- Pharmaceutical segment profit $507M (+18%); Medical segment profit $71M vs. ($8M) loss.
- FY2024 non-GAAP EPS guidance raised to $6.75-$7.00 from $6.50-$6.75; pharma profit growth outlook raised to 7%-9%.
- Interest and other expense guidance reduced to $100M-$120M; diluted shares ~249M.

## SEC filing metadata
- accession: 0000721371-23-000083
- form_type: 8-K
- ticker: CAH
- cik: 0000721371
- company_name: CARDINAL HEALTH INC
- filed_at: 2023-11-03T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/721371/000072137123000083/0000721371-23-000083-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/721371/000072137123000083/cah-20231103.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000721371-23-000083
- JSON: https://secwatch.observer/filing/0000721371-23-000083.json
- Plain text: https://secwatch.observer/filing/0000721371-23-000083.txt

## Key facts
- Earnings Releases
  CARDINAL HEALTH INC reported the quarter ended September 30, 2023 results: revenue $54.8 billion, net income $5 million, EPS $0.02. Guidance raised.
  - Period: the quarter ended September 30, 2023
  - Revenue: $54.8 billion
  - Net income: $5 million
  - EPS: $0.02
  - Guidance: raised
  - Result: reported results
  source text: report. --- EX-99.1 (EX-99.1) --- FOR IMMEDIATE RELEASE Cardinal Health Reports First Quarter Fiscal 2024 Results and Raises Fiscal 2024 Outlook • Revenue increased 10% to $54.8 billion • GAAP 1 operating loss was $14 million and GAAP diluted EPS was $0.02, driven by a Medical segment goodwill impairment • Non-GAAP operating earnings increased 35% to $571
  evidence_url: https://www.sec.gov/Archives/edgar/data/721371/000072137123000083/0000721371-23-000083-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.